Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cardiovascular benefits found for transdermal vs. oral estrogen in postmenopausal women

May 5, 2003

Merck claims androgen receptor modulators for use in bone disorders

May 2, 2003

French team prepares and tests new agents with hypoglycemic and lipid lowering activity

May 2, 2003

New RXR agonists and their use in diabetes and obesity disclosed by GSK

May 2, 2003

Zoledronic acid reduces skeletal morbidity associated with prostate cancer

May 2, 2003

Low-dose Premarin receives FDA approval

April 30, 2003

Bayer researchers discover serine-based alphav integrin antagonists

April 30, 2003

Clomiphene citrate increases endogenous testosterone levels in PHAM

April 30, 2003

Testim reported safe and effective for treating male hypogonadism

April 30, 2003

New cathepsin inhibitors with utility in osteoporosis therapy reported by Celera

April 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...